Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCOR-1: Convalescent Plasma for Hospitalized COVID-19
NCT04348656Phase 3Terminated
- Sponsor
- Hamilton Health Sciences
- Start
- Mar 2020
- Primary completion
- Mar 2021
- Modality
- Biologic
- Countries
- 3
01
Overview
A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Hamilton Health Sciences. Started Mar 2020; status: terminated.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04348656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348656.